Allworth Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Allworth Financial's BMY Position: Q2 2026 in Review
Allworth Financial reduced its Bristol-Myers Squibb (BMY) stake by 41% in Q2 2026, selling an estimated $5.25M and leaving 129,525 shares worth $7.46M. The position accounts for 0.03% of the portfolio, ranked #283.
Allworth Financial first reported a position in BMY in Q3 2013 and has held it in 51 quarters since. The position peaked at $13.4M in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Allworth Financial held 129,525 shares of Bristol-Myers Squibb worth $7.46M as of Q2 2026.
- Allworth Financial sold 91,375 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.25M.
- Bristol-Myers Squibb made up 0.03% of Allworth Financial's portfolio in Q2 2026, its #283 holding.
- Allworth Financial first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 51 quarters since.
- Allworth Financial's Bristol-Myers Squibb position peaked at $13.4M in Q1 2026.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.